Jeffrey R Marks

发表

Prediction of Upstaged Ductal Carcinoma In Situ Using Forced Labeling and Domain Adaptation

Rui Hou, Maciej A Mazurowski, Lars J. Grimm, 2020, IEEE Transactions on Biomedical Engineering.

Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.

Mark Sherman, Honglin Song, Rebecca Sutphen, 2009, Cancer research.

Gene Expression Patterns That Characterize Advanced Stage Serous Ovarian Cancers

Jeffrey R Marks, H. Dressman, J. Nevins, 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility

Stephen R. Piccolo, Irene L Andrulis, William Evan Johnson, 2016, Molecular systems biology.

Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.

Jun Yao, Kornelia Polyak, Cameron Brennan, 2006, Cancer research.

Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

Jingqin Luo, Douglas A Levine, Edwin S Iversen, 2009, Clinical Cancer Research.

Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?

Maciej A Mazurowski, Lars J. Grimm, Ashirbani Saha, 2017, Journal of magnetic resonance imaging : JMRI.

Do serum biomarkers really measure breast cancer

Sayan Mukherjee, Joseph Y Lo, Jonathan L Jesneck, 2009 .

Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.

Francesmary Modugno, Honglin Song, Danielle Shadforth, 2007, Cancer research.

Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium

Hannah Yang, Shan Wang-Gohrke, Honglin Song, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Cyclin E Overexpression in Epithelial Ovarian Cancer Characterizes an Etiologic Subgroup

Susan Halabi, Brian Calingaert, Rex C Bentley, 2008, Cancer Epidemiology Biomarkers & Prevention.

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Dong Liang, Jane E. Carpenter, Peter Kraft, 2016 .

Development of an ovarian cancer screening decision model that incorporates disease heterogeneity

Gillian D Sanders, Jeffrey R Marks, A. Berchuck, 2011, Cancer.

The LINK-A lncRNA interacts with PI(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors

Leng Han, Jun Li, Yan Zhou, 2017, Nature Cell Biology.